Azitra, Inc.

About Azitra, Inc.

Azitra is a clinical-stage precision dermatology company focused on developing novel therapeutics for adverse skin conditions and diseases. They leverage genetic engineering, proteomics, and the skin microbiome to create innovative products for treating skin diseases.

Products & Services

ATR-12:LEKTI-secreting auxotrophic S. epidermidis for Netherton syndrome.

ATR-04:Auxotrophic S. epidermidis for EGFR inhibitor-associated rash.

ATR-01:Filaggrin protein for ichthyosis vulgaris.

Specialties

Genetic Engineering Proteomics Skin Microbiome Microbial Drug Delivery Protein Engineering

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 1500000 MR: - FA: 1.5 Million FAN: 1500000	D: 2025-11-24 FD: 2025-11-24	1 investors
2	RT: Share Purchase Agreement T: - FT: Share Purchase Agreement	A: 20000000 MR: - FA: up to $20 million FAN: 20000000	D: 2025-04-24 FD: 2025-04-24	1 investors
3	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 930000 MR: - FA: $930.0 Thousand FAN: 930000	D: 2025-02-04 FD: 2025-02-04	1 investors
4	RT: Public Offering T: - FT: Public Offering	A: 1500000 MR: - FA: approximately $1.5 million FAN: 1500000	D: 2025-01-15 FD: 2025-01-15	1 investors
5	RT: Public Offering T: - FT: Public Offering	A: 5000000 MR: - FA: approximately $5 million FAN: 5000000	D: 2024-07-25 FD: 2024-07-25	1 investors
6	RT: Public Offering T: - FT: Public Offering	A: 10000000 MR: - FA: $10.0 million FAN: 10000000	D: 2024-07-23 FD: 2024-07-23	1 investors
7	RT: Initial Public Offering T: - FT: Initial Public Offering	A: 7500000 MR: - FA: $7,500,000 FAN: 7500000	D: 2023-06-21 FD: 2023-06-21	1 investors
8	RT: Initial Public Offering T: - FT: Initial Public Offering	A: 7500000 MR: - FA: $7,500,000 FAN: 7500000	D: 2023-06-15 FD: 2023-06-15	1 investors

Private Placement Latest

2025-11-24

$1.5M

1 investor (Pro only)

Share Purchase Agreement 2025-04-24

$20.0M

Registered Direct Offering 2025-02-04

$930K

View 7 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

F

Francisco Salva

President and CEO

T

Travis Whitfill

Cofounder and Chief Operating Officer

N

Norman Staskey

Chief Financial Officer

B

Barbara Ryan

Senior Advisor, EY

J

John R. Schroer

Chief Financial Officer, Alumis

J

Julia Oh

Assistant Professor at The Jackson Laboratory for Genomic Medicine

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

Azitra, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised